References
- Andremont A, Raibaud P, Tancrède C. Effect of erythromycin on microbial antagonisms: a study in gnotobiotic mice associated with a human faecal flora. Journal of Infectious Diseases 1983; 148: 579–587
- Aranki A, Syed S A, Kenney E B, Freter A. Isolation of anaerobic bacteria from human gingiva and mouse cecum by means of a simplified glove-box procedure. Applied Microbiology 1969; 17: 568–576
- Brogard J M, Arnaud J P, Buckle J F, Levy P, Dorner M, Lautier F. Biliary elimination of cefotiam, an experimental and clinical study. Chemotherapy 1986; 32: 222–235
- Chabbert Y A, Boulingre H. Modifications pratiques concernant le dosage des antibiotiques en clinique. Revue Française des Etudes Cliniques et Biologiques 1957; 2: 636–640
- Chen J, Cummins J, Johnson R, Smibert L, Wilkins T. Genera of anaerobic bacteria. Anaerobes Laboratory Manual, 4th edn, L Holdman, E Cato, E Moore. Virginia Polytechnic Institute and State University, Blacksburg 1977; 11
- Ducluzeau R, Ladire M, Callut C, Raibaud P, Abrams G D. Antagonistic effect of extremely oxygen-sensitive Clostridia from the microflora of conventional mice and of Escherichia coli against Shigella flexneri in the digestive tract of gnotobiotic mice. Infection and Immunity 1977; 17: 415–424
- Leonard F, Andremont A, Leclercq B, Labia R, Tancrède C. Use of beta-lactamase-producing anaerobes to prevent ceftriaxone from degrading intestinal resistance to colonization. Journal of Infectious Diseases 1989; 160: 274–280
- Mishimura T, Yoshimura Y, Miyaka A, Yamoaka M, Takanohashi K, Hamaguchi M, Hirai S, Yashiki T, Mumata M. Orally active l-(cyclohexyl-carbonyloxy) alkyl ester prodrugs of cefotiam. Journal of Antibiotics 1987; 63: 81–90
- Neu H C. β-lactam antibiotics: structural relationships affecting in vitro activity and pharmacologic properties. Reviews of Infectious Diseases 1986; 8: S237–S259
- O'Callaghan C H, Morris A, Kirby S M, Shingler A H. Novel method for detection of beta-lactamase by using a chromogenic cephalosporin substrate. Antimicrobial Agents and Chemotherapy 1972; 1: 283–288
- Pecquet S, Andremont A, Tancrède C. Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora. Antimicrobial Agents and Chemotherapy 1986; 29: 1047–1052
- Rolfe R D, Finegold S. Intestinal beta-lactamase activity in ampicillin-induced Clostridium difficile associated ileocecitis. Journal of Infectious Diseases 1983; 147: 227–235
- Rosembaum M. Cefotiam Hexetil (SCE 2174). Brochure Pour Investigateur du Produit. Laboratoires Takeda, Paris 1987
- Steers E, Foltz E L, Gravies B S, Riden J. An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antibiotics and Chemotherapy (Basel) 1959; 9: 307–311
- Yoshimura Y, Hamaguchi M, Yashiki T. Preparation of 1-acyloxyethyl esters of 7-[2-aminothiazol-4-YL) acetamidol]-3-[1-(2-dimethyl-aminoethyl)-1-H-tetrazol-5-YL]theo]-methyl] ceph-3-em-4-carboxyl acid (cefotiam) and their oral absorption in mice. Journal of Antibiotics 1986; 39: 1329–1342